QA: LIXTE BIOTECHNOLOGY HOLDINGS INC. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335105_2018_LIXTE_BIOTECHNOLOGY_HOLDINGS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001335105')"}

Graph

Absolute values for 0001335105, LIXTE BIOTECHNOLOGY HOLDINGS INC.

  xvar xval
0 AssetsCurrent 1,368,065
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 373,024
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,342,531
9 ResearchAndDevelopmentExpense 467,258
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,375
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 1,368,065
1 Liabilities 373,024
2 Expenses 1,809,789
3 Revenues 0
4 StockholdersEquity 995,041
5 NetIncome -1,808,414
6 ComprehensiveNetIncome -1,808,414
7 BaseVar 1,776,126
8 EconomicCapitalRatio -0.111

Edgar->Model Mapping

Feature Distribution

Change over Time